Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Heterologous expression of leader-less pga gene in Pichia pastoris: intracellular production of prokaryotic enzyme

H. Marešová, Z. Marková, R. Valešová, J. Sklenář, P. Kyslík

. 2010 ; 10 () : 7. [pub] 20100203

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025234

BACKGROUND: Penicillin G acylase of Escherichia coli (PGAEc) is a commercially valuable enzyme for which efficient bacterial expression systems have been developed. The enzyme is used as a catalyst for the hydrolytic production of beta-lactam nuclei or for the synthesis of semi-synthetic penicillins such as ampicillin, amoxicillin and cephalexin. To become a mature, periplasmic enzyme, the inactive prepropeptide of PGA has to undergo complex processing that begins in the cytoplasm (autocatalytic cleavage), continues at crossing the cytoplasmic membrane (signal sequence removing), and it is completed in the periplasm. Since there are reports on impressive cytosolic expression of bacterial proteins in Pichia, we have cloned the leader-less gene encoding PGAEc in this host and studied yeast production capacity and enzyme authenticity. RESULTS: Leader-less pga gene encoding PGAEcunder the control of AOX1 promoter was cloned in Pichia pastoris X-33. The intracellular overproduction of heterologous PGAEc(hPGAEc) was evaluated in a stirred 10 litre bioreactor in high-cell density, fed batch cultures using different profiles of transient phases. Under optimal conditions, the average volumetric activity of 25900 U l-1 was reached. The hPGAEc was purified, characterized and compared with the wild-type PGAEc. The alpha-subunit of the hPGAEc formed in the cytosol was processed aberrantly resulting in two forms with C- terminuses extended to the spacer peptide. The enzyme exhibited modified traits: the activity of the purified enzyme was reduced to 49%, the ratios of hydrolytic activities with cephalexin, phenylacetamide or 6-nitro-3-phenylacetylamidobenzoic acid (NIPAB) to penicillin G increased and the enzyme showed a better synthesis/hydrolysis ratio for the synthesis of cephalexin. CONCLUSIONS: Presented results provide useful data regarding fermentation strategy, intracellular biosynthetic potential, and consequences of the heterologous expression of PGAEc in P. pastoris X-33. Aberrant processing of the precursor of PGAEc in the cytosol yielded the mature enzyme with modified traits.

000      
00000naa a2200000 a 4500
001      
bmc12025234
003      
CZ-PrNML
005      
20221005162323.0
007      
ta
008      
120816e20100203enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/1472-6750-10-7 $2 doi
035    __
$a (PubMed)20128906
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Marešová, Helena $7 xx0128749 $u Laboratory of Enzyme Technology, Institute of Microbiology, vvi, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic.
245    10
$a Heterologous expression of leader-less pga gene in Pichia pastoris: intracellular production of prokaryotic enzyme / $c H. Marešová, Z. Marková, R. Valešová, J. Sklenář, P. Kyslík
520    9_
$a BACKGROUND: Penicillin G acylase of Escherichia coli (PGAEc) is a commercially valuable enzyme for which efficient bacterial expression systems have been developed. The enzyme is used as a catalyst for the hydrolytic production of beta-lactam nuclei or for the synthesis of semi-synthetic penicillins such as ampicillin, amoxicillin and cephalexin. To become a mature, periplasmic enzyme, the inactive prepropeptide of PGA has to undergo complex processing that begins in the cytoplasm (autocatalytic cleavage), continues at crossing the cytoplasmic membrane (signal sequence removing), and it is completed in the periplasm. Since there are reports on impressive cytosolic expression of bacterial proteins in Pichia, we have cloned the leader-less gene encoding PGAEc in this host and studied yeast production capacity and enzyme authenticity. RESULTS: Leader-less pga gene encoding PGAEcunder the control of AOX1 promoter was cloned in Pichia pastoris X-33. The intracellular overproduction of heterologous PGAEc(hPGAEc) was evaluated in a stirred 10 litre bioreactor in high-cell density, fed batch cultures using different profiles of transient phases. Under optimal conditions, the average volumetric activity of 25900 U l-1 was reached. The hPGAEc was purified, characterized and compared with the wild-type PGAEc. The alpha-subunit of the hPGAEc formed in the cytosol was processed aberrantly resulting in two forms with C- terminuses extended to the spacer peptide. The enzyme exhibited modified traits: the activity of the purified enzyme was reduced to 49%, the ratios of hydrolytic activities with cephalexin, phenylacetamide or 6-nitro-3-phenylacetylamidobenzoic acid (NIPAB) to penicillin G increased and the enzyme showed a better synthesis/hydrolysis ratio for the synthesis of cephalexin. CONCLUSIONS: Presented results provide useful data regarding fermentation strategy, intracellular biosynthetic potential, and consequences of the heterologous expression of PGAEc in P. pastoris X-33. Aberrant processing of the precursor of PGAEc in the cytosol yielded the mature enzyme with modified traits.
650    _2
$a bioreaktory $7 D019149
650    _2
$a klonování DNA $7 D003001
650    _2
$a Escherichia coli $x enzymologie $x genetika $7 D004926
650    _2
$a proteiny z Escherichia coli $x biosyntéza $x genetika $x izolace a purifikace $7 D029968
650    _2
$a fermentace $7 D005285
650    _2
$a průmyslová mikrobiologie $7 D007218
650    _2
$a penicilinamidasa $x biosyntéza $x genetika $x izolace a purifikace $7 D010399
650    _2
$a Pichia $x genetika $x metabolismus $7 D010843
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a spektrometrie hmotnostní - ionizace laserem za účasti matrice $7 D019032
650    _2
$a substrátová specifita $7 D013379
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Marková, Zdena
700    1_
$a Valešová, Renáta $7 xx0103423
700    1_
$a Sklenář, Jan $7 xx0137801
700    1_
$a Kyslík, Pavel, $d 1949- $7 xx0097730
773    0_
$w MED00008169 $t BMC biotechnology $x 1472-6750 $g Roč. 10 (20100203), s. 7
856    41
$u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845550/ $y plný text volně přístupný
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20221005162318 $b ABA008
999    __
$a ok $b bmc $g 947276 $s 782580
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 10 $d 7 $e 20100203 $i 1472-6750 $m BMC biotechnology $n BMC Biotechnol $x MED00008169
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...